Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children

Justen H. Passwell*, Shai Ashkenazi, Efrat Harlev, Dan Miron, Reut Ramon, Nahid Farzam, Liat Lerner-geva, Yonit Levi, Chiayung Chu, Joseph Shiloach, John B. Robbins, Rachel Schneerson

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

89 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science